The design of artificial retroviral restriction factors
Authors:
- Gulnahar B. MortuzaGMGulnahar B. Mortuza
- Ian A. TaylorITIan A. Taylor
- Jonathan P. StoyeJSJonathan P. Stoye
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 ProteinsJournal of Virology, 2006
- Characterization of an Amino-Terminal Dimerization Domain from Retroviral Restriction Factor Fv1Journal of Virology, 2006
- Removal of Arginine 332 Allows Human TRIM5α To Bind Human Immunodeficiency Virus Capsids and To Restrict InfectionJournal of Virology, 2006
- Functional Replacement of the RING, B-Box 2, and Coiled-Coil Domains of Tripartite Motif 5α (TRIM5α) by Heterologous TRIM DomainsJournal of Virology, 2006
- Proteasome inhibitors uncouple rhesus TRIM5α restriction of HIV-1 reverse transcription and infectionProceedings of the National Academy of Sciences, 2006
- Trim-Cyclophilin A Fusion Proteins Can Restrict Human Immunodeficiency Virus Type 1 Infection at Two Distinct Phases in the Viral Life CycleJournal of Virology, 2006
- High-resolution structure of a retroviral capsid hexameric amino-terminal domainNature, 2004
- The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeysNature, 2004
- In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epitheliumGene Therapy, 2001
- Molecular recognition in the HIV-1 capsid/cyclophilin A complex 1 1Edited by J. A. WellsJournal of Molecular Biology, 1997